Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3459)
All Articles published online
|
Feb 28, 2006 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhou L, Liu J, Luo F. Serum tumor markers for detection of hepatocellular carcinoma. World J Gastroenterol 2006; 12(8): 1175-1181 [PMID: 16534867 DOI: 10.3748/wjg.v12.i8.1175] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v12/i8/1175.htm |
| Number | Citing Articles |
| 1 |
Yun Hee Kang, Mi-Young Park, Do-Young Yoon, Seung Ro Han, Chung Il Lee, Na Young Ji, Pyung-Keun Myung, Hee Gu Lee, Jae Wha Kim, Young Il Yeom, Ye Jin Jang, Dong Kuk Ahn, Jong Wan Kim, Eun Young Song. Dysregulation of overexpressed IL-32α in hepatocellular carcinoma suppresses cell growth and induces apoptosis through inactivation of NF-κB and Bcl-2. Cancer Letters 2012; 318(2): 226 doi: 10.1016/j.canlet.2011.12.023
|
| 2 |
Fabio Grizzi, Barbara Franceschini, Barbara Fiamengo, Carlo Russo, Nicola Dioguardi. Vascular architecture: is it a helpful histopathological biomarker for hepatocellular carcinoma?. Journal of Zhejiang University SCIENCE B 2007; 8(4): 217 doi: 10.1631/jzus.2007.B0217
|
| 3 |
Takashi Sugihara, Satoshi Tanaka, Ignacia Braga-Tanaka, Hayato Murano, Masako Nakamura-Murano, Jun-ichiro Komura. Screening of biomarkers for liver adenoma in low-dose-rate γ-ray-irradiated mice. International Journal of Radiation Biology 2018; 94(4): 315 doi: 10.1080/09553002.2018.1439193
|
| 4 |
Lien-Chin Chen, Mei-Ying Liu, Yung-Chin Hsiao, Wai-Kok Choong, Hsin-Yi Wu, Wen-Lian Hsu, Pao-Chi Liao, Ting-Yi Sung, Shih-Feng Tsai, Jau-Song Yu, Yu-Ju Chen. Decoding the Disease-Associated Proteins Encoded in the Human Chromosome 4. Journal of Proteome Research 2013; 12(1): 33 doi: 10.1021/pr300829r
|
| 5 |
Mariam M. Abdelkhalek Elhefni, Amr A. Abd El Moety, Nahed M. Baddour, Perihan El Sayed Salem. The Role of Human U Three Protein 14a as a Predictor for Hepatocellular Carcinoma Recurrence After Microwave Ablation. Applied Immunohistochemistry & Molecular Morphology 2022; 30(3): 171 doi: 10.1097/PAI.0000000000000994
|
| 6 |
Yu Li, Jing Xu, Li Chen, Wei‐De Zhong, Zheng Zhang, Li Mi, Yang Zhang, Cheng‐Gong Liao, Hui‐Jie Bian, Jian‐Li Jiang, Xiang‐Min Yang, Xiao‐Yan Li, Chun‐Mei Fan, Ping Zhu, Li Fu, Zhi‐Nan Chen. HAb18G (CD147), a cancer‐associated biomarker and its role in cancer detection. Histopathology 2009; 54(6): 677 doi: 10.1111/j.1365-2559.2009.03280.x
|
| 7 |
Aditya Kale. Hepatocellular Carcinoma - Challenges and Opportunities of a Multidisciplinary Approach. 2022; doi: 10.5772/intechopen.99839
|
| 8 |
Xinyu Zhu, Zhiwei Li, Li Chen, Limin Li, Mi Ouyang, Hao Zhou, Kai Xiao, Ling Lin, Paul K. Chu, Chang Zhou, Chengfeng Xun, Liu Yang, Wenhuan Huang, Xiaofeng Ding. Targeting KCTD1 as a Potential Novel Therapy Ameliorates Hepatocellular Carcinoma Progression via the HIF-1α/VEGF Pathway. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4047141
|
| 9 |
Yongmei Wu, Wenju Xu, Yan Wang, Yali Yuan, Ruo Yuan. Silver–graphene oxide nanocomposites as redox probes for electrochemical determination of α-1-fetoprotein. Electrochimica Acta 2013; 88: 135 doi: 10.1016/j.electacta.2012.10.081
|
| 10 |
Dalia Omran, Serag Esmat, Heba Sedrac, Ahmad ElBadry, Dina Ismail, Laila Rashed. Can we use GP73 as a biomarker for the detection of hepatocellular carcinoma?. Egyptian Liver Journal 2011; 1(1): 43 doi: 10.1097/01.ELX.0000397027.33294.16
|
| 11 |
Xishan Li, Jianpeng Wang, Wang Li, Zilin Huang, Weijun Fan, Yumin Chen, Lijie Shen, Tao Pan, Peihong Wu, Ming Zhao. Percutaneous CT-guided radiofrequency ablation for unresectable hepatocellular carcinoma pulmonary metastases. International Journal of Hyperthermia 2012; 28(8): 721 doi: 10.3109/02656736.2012.736669
|
| 12 |
Gang Hu, Jaakko Tuomilehto, Eero Pukkala, Timo Hakulinen, Riitta Antikainen, Erkki Vartiainen, Pekka Jousilahti. Joint effects of coffee consumption and serum gamma‐glutamyltransferase on the risk of liver cancer. Hepatology 2008; 48(1): 129 doi: 10.1002/hep.22320
|
| 13 |
Ishfaq Hassan Mir, K. C. Jyothi, Chinnasamy Thirunavukkarasu. The prominence of potential biomarkers in the diagnosis and management of hepatocellular carcinoma: Current scenario and future anticipation. Journal of Cellular Biochemistry 2022; 123(10): 1607 doi: 10.1002/jcb.30190
|
| 14 |
Sukki Cho, Kyung-Min Ryu, Yoon-Jin Hwang, Eung Bae Lee. Prognostic Factors for Pulmonary Metastasectomy in the Treatment of Hepatocellular Carcinoma. Journal of Thoracic Oncology 2010; 5(8): 1251 doi: 10.1097/JTO.0b013e3181e2fc9b
|
| 15 |
|
| 16 |
Laetitia Fartoux, Thomas Decaens. Contribution of biomarkers and imaging in the management of hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology 2011; 35: S21 doi: 10.1016/S2210-7401(11)70004-3
|
| 17 |
Shreetama Bandyopadhayaya, Chandi C. Mandal. Precision Medicine in Oncology. 2020; : 61 doi: 10.1002/9781119432487.ch2
|
| 18 |
Manjula Kiran, Yogesh K. Chawla, Meenu Jain, Jyotdeep Kaur. Haplotypes of Microsomal Epoxide Hydrolase and X-Ray Cross-Complementing Group 1 Genes in Indian Hepatocellular Carcinoma Patients. DNA and Cell Biology 2009; 28(11): 573 doi: 10.1089/dna.2009.0921
|
| 19 |
Xiaoyue Zhang, Xiang Ren, Wei Cao, Yueyun Li, Bin Du, Qin Wei. Simultaneous electrochemical immunosensor based on water-soluble polythiophene derivative and functionalized magnetic material. Analytica Chimica Acta 2014; 845: 85 doi: 10.1016/j.aca.2014.05.025
|
| 20 |
Young Sun Kim, Kyung Nam Kang, Yong Sung Shin, Ji Eun Lee, Ji Young Jang, Chul Woo Kim. Diagnostic value of combining tumor and inflammatory biomarkers in detecting common cancers in Korea. Clinica Chimica Acta 2021; 516: 169 doi: 10.1016/j.cca.2021.02.002
|
| 21 |
Michael D. Lucroy. Clinical Biochemistry of Domestic Animals. 2008; : 751 doi: 10.1016/B978-0-12-370491-7.00025-8
|
| 22 |
Alicja Chrzanowska, Wojciech Graboń, Magdalena Mielczarek-Puta, Anna Barańczyk-Kuźma. Significance of arginase determination in body fluids of patients with hepatocellular carcinoma and liver cirrhosis before and after surgical treatment. Clinical Biochemistry 2014; 47(12): 1056 doi: 10.1016/j.clinbiochem.2014.03.019
|
| 23 |
Liming Zheng, Zeyu Huang, Xiaoping Li, Meifang He, Xiaoqin Liu, Guojun Zheng, Xike Zhou, Longgen Liu. Construction and validation of a predictive model for hepatocellular carcinoma based on serum markers. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02489-2
|
| 24 |
Tejaswini Reddy, Abdullah Esmail, Jenny C. Chang, Rafik Mark Ghobrial, Maen Abdelrahim. Utility of Cell-Free DNA Detection in Transplant Oncology. Cancers 2022; 14(3): 743 doi: 10.3390/cancers14030743
|
| 25 |
Selena Y. Lin, Wei Xia, Amy K. Kim, Dion Chen, Shelby Schleyer, Lin Choi, Zhili Wang, James P. Hamilton, Harry Luu, Hie-Won Hann, Ting-Tsung Chang, Chi-Tan Hu, Abashai Woodard, Terence P. Gade, Ying-Hsiu Su. Novel urine cell-free DNA methylation markers for hepatocellular carcinoma. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-48500-y
|
| 26 |
Patricia Aguilar-Melero, María-José Prieto-Álamo, Juan Jurado, Arne Holmgren, Carmen Pueyo. Proteomics in HepG2 hepatocarcinoma cells with stably silenced expression of PRDX1. Journal of Proteomics 2013; 79: 161 doi: 10.1016/j.jprot.2012.12.005
|
| 27 |
William E. Owen, Richard F. Roberts, William L. Roberts. Performance characteristics of the LiBASys® des-gamma-carboxy prothrombin assay. Clinica Chimica Acta 2008; 389(1-2): 183 doi: 10.1016/j.cca.2007.11.031
|
| 28 |
Raghu Aarthy, Samson Mani, Sridevi Velusami, Shirley Sundarsingh, Thangarajan Rajkumar. Role of Circulating Cell-Free DNA in Cancers. Molecular Diagnosis & Therapy 2015; 19(6): 339 doi: 10.1007/s40291-015-0167-y
|
| 29 |
Collin Bachert, Claus Fimmel, Adam D. Linstedt. Endosomal Trafficking and Proprotein Convertase Cleavage of cis Golgi Protein GP73 Produces Marker for Hepatocellular Carcinoma. Traffic 2007; 8(10): 1415 doi: 10.1111/j.1600-0854.2007.00621.x
|
| 30 |
Gabriele Catyana Krause, Kelly Goulart Lima, Gabriela Viegas Haute, Aline Daniele Schuster, Henrique Bregolin Dias, Fernanda Cristina Mesquita, Leonardo Pedrazza, Elisa Simon Marczak, Bruno Souza Basso, Anderson Catarina Velasque, Bianca Andrade Martha, Fernanda Bordignon Nunes, Márcio Vinícius Fagundes Donadio, Jarbas Rodrigues de Oliveira. Fructose-1,6-bisphosphate decreases IL-8 levels and increases the activity of pro-apoptotic proteins in HepG2 cells. Biomedicine & Pharmacotherapy 2017; 89: 358 doi: 10.1016/j.biopha.2017.01.178
|
| 31 |
Ying Sun, Xiaoyuan Zheng, Hui Yuan, Geng Chen, Jiahe Ouyang, Jingfeng Liu, Xiaolong Liu, Xiaohua Xing, Bixing Zhao. Proteomic analyses reveal divergent ubiquitylation patterns in hepatocellula carcinoma cell lines with different metastasis potential. Journal of Proteomics 2020; 225: 103834 doi: 10.1016/j.jprot.2020.103834
|
| 32 |
Hao Zhang, Xuebing Chen, Jian Zhang, Xianwei Wang, Huijuan Chen, Lin Liu, Shanling Liu. Long non‑coding RNAs in HBV‑related hepatocellular carcinoma (Review). International Journal of Oncology 2019; doi: 10.3892/ijo.2019.4909
|
| 33 |
Yoshinori INAGAKI, Huan Li XU, Kiyoshi HASEGAWA, Taku AOKI, Yoshifumi BECK, Yasuhiko SUGAWARA, Wei TANG, Norihiro KOKUDO. Des‐gamma‐carboxyprothrombin in patients with hepatocellular carcinoma and liver cirrhosis. Journal of Digestive Diseases 2011; 12(6): 481 doi: 10.1111/j.1751-2980.2011.00521.x
|
| 34 |
Ya-Wen Chen, Huay-Ben Pan, Hui-Hwa Tseng, Yu-Ting Hung, Jer-Shyung Huang, Chen-Pin Chou. Assessment of Blood Flow in Hepatocellular Carcinoma: Correlations of Computed Tomography Perfusion Imaging and Circulating Angiogenic Factors. International Journal of Molecular Sciences 2013; 14(9): 17536 doi: 10.3390/ijms140917536
|
| 35 |
Ibtisam M. Farid, Iman M. Hamza, Dina M. El-Abd, Abeer M. Mohyi, Mona M.A. AbdulLatif, Adel T. Aref, Dina M. Hamza. Transforming growth factor-β1 gene expression in hepatocellular carcinoma: A preliminary report. Arab Journal of Gastroenterology 2014; 15(3-4): 142 doi: 10.1016/j.ajg.2014.10.007
|
| 36 |
Debayan Banik, Prasun Patra. Possibility of Liver Cancer Treatment By Nanoformulation of Phenolic
Phytochemicals. Current Nanomedicine 2022; 12(2): 108 doi: 10.2174/2468187312666220908094042
|
| 37 |
Wei Li, Philip T Cagle, Rafael C Botero, John J Liang, Zhaoping Zhang, Dongfeng Tan. Significance of overexpression of alpha methylacyl-coenzyme A racemase in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research 2008; 27(1) doi: 10.1186/1756-9966-27-2
|
| 38 |
Agnieszka Kopystecka, Rafał Patryn, Magdalena Leśniewska, Julia Budzyńska, Ilona Kozioł. The Use of ctDNA in the Diagnosis and Monitoring of Hepatocellular Carcinoma—Literature Review. International Journal of Molecular Sciences 2023; 24(11): 9342 doi: 10.3390/ijms24119342
|
| 39 |
Roberta W. C. Pang, Jae Won Joh, Philip J. Johnson, Morito Monden, Timothy M. Pawlik, Ronnie T. P. Poon. Biology of Hepatocellular Carcinoma. Annals of Surgical Oncology 2008; 15(4): 962 doi: 10.1245/s10434-007-9730-z
|
| 40 |
Yuling Gan, Qiuzhen Liang, Xinghua Song. Diagnostic value of alpha-l-fucosidase for hepatocellular carcinoma: a meta-analysis. Tumor Biology 2014; 35(5): 3953 doi: 10.1007/s13277-013-1563-8
|
| 41 |
Shilu Mathew, Ashraf Ali, Hany Abdel-Hafiz, Kaneez Fatima, Mohd Suhail, Govindaraju Archunan, Nargis Begum, Syed Jahangir, Muhammad Ilyas, Adeel G.A. Chaudhary, Mohammad Al Qahtani, Salem Mohamad Bazarah, Ishtiaq Qadri. Biomarkers for virus-induced hepatocellular carcinoma (HCC). Infection, Genetics and Evolution 2014; 26: 327 doi: 10.1016/j.meegid.2014.06.014
|
| 42 |
Ivonne Nel, Hideo A Baba, Frank Weber, Barbara Sitek, Martin Eisenacher, Helmut E Meyer, Joerg F Schlaak, Andreas-Claudius Hoffmann. IGFBP1 in epithelial circulating tumor cells as a potential response marker to selective internal radiation therapy in hepatocellular carcinoma. Biomarkers in Medicine 2014; 8(5): 687 doi: 10.2217/bmm.14.23
|
| 43 |
Asmaa I Gomaa, Shahid A Khan, Edward LS Leen, Imam Waked, Simon D Taylor-Robinson. Diagnosis of hepatocellular carcinoma. World Journal of Gastroenterology 2009; 15(11): 1301-1314 doi: 10.3748/wjg.15.1301
|
| 44 |
Nahla M. Shalably, Rehab Badawi, Nehad Hawash, Sherief Abd-Elsalam, Walaa Elkhalawany, Amal Abd EI Hameed, Galal El-Din Alkassas. Evaluation of Fucosylated Haptoglobin as a Diagnostic Biomarker for Hepatocellular Carcinoma in Egypt. The Open Biomarkers Journal 2019; 9(1): 31 doi: 10.2174/1875318301909010031
|
| 45 |
Jeong-Yeop Song, Yun Nah Lee, Young Seok Kim, Sang Gyune Kim, Soo Ji Jin, Jung Mi Park, Gyu Seong Choi, Jun Chul Chung, Min Hee Lee, Youn Hee Cho, Moon Han Choi, Dong Choon Kim, Hyun Jong Choi, Jong Ho Moon, Se Hwan Lee, Seung Won Jeong, Jae Young Jang, Hong Soo Kim, Boo Sung Kim. Predictability of preoperative 18F-FDG PET for histopathological differentiation and early recurrence of primary malignant intrahepatic tumors. Nuclear Medicine Communications 2015; 36(4): 319 doi: 10.1097/MNM.0000000000000254
|
| 46 |
Nikita Sehgal, Ruchi Jakhmola Mani, Nitu Dogra, Deepshikha Pande Katare. Biosensor Based Advanced Cancer Diagnostics. 2022; : 97 doi: 10.1016/B978-0-12-823424-2.00009-0
|
| 47 |
Yun Hee Kang, Na Young Ji, Chung Il Lee, Hee Gu Lee, Jae Wha Kim, Young IL Yeom, Dae Ghon Kim, Seung Kew Yoon, Jong Wan Kim, Pil Je Park, Eun Young Song. ESM-1 silencing decreased cell survival, migration, and invasion and modulated cell cycle progression in hepatocellular carcinoma. Amino Acids 2011; 40(3): 1003 doi: 10.1007/s00726-010-0729-6
|
| 48 |
Long Zhao, Chao Xie, Danqing Liu, Tong Li, Yu Zhang, Chidan Wan. Early Detection of Hepatocellular Carcinoma in Patients with Hepatocirrhosis by Soluble B7-H3. Journal of Gastrointestinal Surgery 2017; 21(5): 807 doi: 10.1007/s11605-017-3386-1
|
| 49 |
Mallikarjun Patil, Keyur A. Sheth, Channagiri K. Adarsh. Elevated Alpha Fetoprotein, No Hepatocellular Carcinoma. Journal of Clinical and Experimental Hepatology 2013; 3(2): 162 doi: 10.1016/j.jceh.2013.02.246
|
| 50 |
JuanPing Yu, Qiang Ma, Bin Zhang, RuiJuan Ma, XiGuang Xu, MingSong Li, WeiWen Xu, Ming Li. Clinical application of specific antibody against glypican-3 for hepatocellular carcinoma diagnosis. Science China Life Sciences 2013; 56(3): 234 doi: 10.1007/s11427-013-4451-y
|
| 51 |
Wei Feng Low, Yun Fong Ngeow, Jack Bee Chook, Kok Keng Tee, Seng-Kai Ong, Suat Cheng Peh, Jan Jin Bong, Rosmawati Mohamed. Hepatitis B virus DNA methylation and its potential role in chronic hepatitis B. Expert Reviews in Molecular Medicine 2023; 25 doi: 10.1017/erm.2022.38
|
| 52 |
Mingming Xiao, Yajing Chen, Huan Yu, Su Wei, Kang Yu, Huan Zhao, Ruibing Chen. Analysis of the whole serum proteome using an integrated 2D LC-MS/MS system. Anal. Methods 2014; 6(18): 7157 doi: 10.1039/C4AY01274G
|
| 53 |
Wei Yin Lim, Boon Tong Goh, Sook Mei Khor. Microfluidic paper-based analytical devices for potential use in quantitative and direct detection of disease biomarkers in clinical analysis. Journal of Chromatography B 2017; 1060: 424 doi: 10.1016/j.jchromb.2017.06.040
|
| 54 |
Vivek K. Chaturvedi, Anshuman Singh, Sushil K. Dubey, Helal F. Hetta, James John, M.P. Singh. Molecular mechanistic insight of hepatitis B virus mediated hepatocellular carcinoma. Microbial Pathogenesis 2019; 128: 184 doi: 10.1016/j.micpath.2019.01.004
|
| 55 |
Won-Hyeong Park, Ju-Hyun Shim, Seung-Bong Han, Hyung-Jin Won, Yong-Moon Shin, Kang-Mo Kim, Young-Suk Lim, Han-Chu Lee. Clinical Utility of Des-γ-Carboxy Prothrombin Kinetics as a Complement to Radiologic Response in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. Journal of Vascular and Interventional Radiology 2012; 23(7): 927 doi: 10.1016/j.jvir.2012.04.021
|
| 56 |
Senthil Rajappa, Kun-Ming Rau, Palanki Satya Dattatreya, Anant Ramaswamy, Philana Fernandes, Aarohan Pruthi, Rebecca Cheng, Mariusz Lukanowski, Yi-Hsiang Huang. Second-line treatment of advanced hepatocellular carcinoma: Time for more individualized treatment options?. World Journal of Hepatology 2022; 14(6): 1074-1086 doi: 10.4254/wjh.v14.i6.1074
|
| 57 |
Ashish Singhal, Muralidharan Jayaraman, Danny N. Dhanasekaran, Vivek Kohli. Molecular and serum markers in hepatocellular carcinoma: Predictive tools for prognosis and recurrence. Critical Reviews in Oncology/Hematology 2012; 82(2): 116 doi: 10.1016/j.critrevonc.2011.05.005
|
| 58 |
Hadeer A Aglan, Hanaa H Ahmed, Sayed A El-Toumy, Nadia S Mahmoud. Gallic acid against hepatocellular carcinoma: An integrated scheme of the potential mechanisms of action fromin vivostudy. Tumor Biology 2017; 39(6): 101042831769912 doi: 10.1177/1010428317699127
|
| 59 |
Masataka Kashima, Koichiro Yamakado, Haruyuki Takaki, Toshio Kaminou, Noboru Tanigawa, Atsuhiro Nakatsuka, Kan Takeda. Radiofrequency Ablation for the Treatment of Bone Metastases From Hepatocellular Carcinoma. American Journal of Roentgenology 2010; 194(2): 536 doi: 10.2214/AJR.09.2975
|
| 60 |
Gary L. Davis, Jane Dempster, James D. Meler, Douglas W. Orr, Mark W. Walberg, Brian Brown, Brian D. Berger, John K. O'Connor, Robert M. Goldstein. Hepatocellular Carcinoma: Management of an Increasingly Common Problem. Baylor University Medical Center Proceedings 2008; 21(3): 266 doi: 10.1080/08998280.2008.11928410
|
| 61 |
Tara Behne, M. Sitki Copur. Biomarkers for Hepatocellular Carcinoma. International Journal of Hepatology 2012; 2012: 1 doi: 10.1155/2012/859076
|
| 62 |
Fei Fan, Haiying Shen, Guojun Zhang, Xingyu Jiang, Xixiong Kang. Chemiluminescence immunoassay based on microfluidic chips for α-fetoprotein. Clinica Chimica Acta 2014; 431: 113 doi: 10.1016/j.cca.2014.02.003
|
| 63 |
Cuiyun Wu, Yaosheng Luo, Yinghui Chen, Hongling Qu, Lin Zheng, Jie Yao. Development of a prognostic gene signature for hepatocellular carcinoma. Cancer Treatment and Research Communications 2022; 31: 100511 doi: 10.1016/j.ctarc.2022.100511
|
| 64 |
Hong Zhang, Feng Li, Qun Wei, Yu-Fei Zhu. Value of combined detection of AFU and TCH in differential diagnosis between malignant and non-tuberculous benign ascites. Medical Oncology 2011; 28(S1): 670 doi: 10.1007/s12032-010-9731-9
|
| 65 |
Edmund Kwok‐Kwan Tung, Carmen Ka‐Man Mak, Sarwat Fatima, Regina Cheuk‐Lam Lo, Heng Zhao, Chunsheng Zhang, Hongyue Dai, Ronnie Tung‐Ping Poon, Man‐Fung Yuen, Ching‐Lung Lai, Jin‐jun Li, John Moon‐Ching Luk, Irene Oi‐Lin Ng. Clinicopathological and prognostic significance of serum and tissueDickkopf‐1levels in human hepatocellular carcinoma. Liver International 2011; 31(10): 1494 doi: 10.1111/j.1478-3231.2011.02597.x
|
| 66 |
Hao Huang, Xue-Ping Wang, Xiao-Hui Li, Hao Chen, Xin Zheng, Jian-Hua Lin, Ting Kang, Lin Zhang, Pei-Song Chen. Prognostic value of pretreatment serum alanine aminotransferase/aspartate aminotransferase (ALT/AST) ratio and gamma glutamyltransferase (GGT) in patients with esophageal squamous cell carcinoma. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3523-y
|
| 67 |
Xinxin Li, Haitao Yu, Xiaohua Gan, Xiaoyuan Xia, Pengcheng Xu, Jungang Li, Min Liu, Yongxiang Li. Integrated MEMS/NEMS Resonant Cantilevers for Ultrasensitive Biological Detection. Journal of Sensors 2009; 2009: 1 doi: 10.1155/2009/637874
|
| 68 |
Svenja Sydor, Christian Dandyk, Johannes Schwerdt, Paul Manka, Dirk Benndorf, Theresa Lehmann, Kay Schallert, Maximilian Wolf, Udo Reichl, Ali Canbay, Lars P. Bechmann, Robert Heyer. Discovering Biomarkers for Non-Alcoholic Steatohepatitis Patients with and without Hepatocellular Carcinoma Using Fecal Metaproteomics. International Journal of Molecular Sciences 2022; 23(16): 8841 doi: 10.3390/ijms23168841
|
| 69 |
Eric C. Han, Ying-Shiung Lee, Wen-Sin Liao, Yu-Ching Liu, Hsin-Yi Liao, Long-Bin Jeng. Direct tissue analysis by MALDI-TOF mass spectrometry in human hepatocellular carcinoma. Clinica Chimica Acta 2011; 412(3-4): 230 doi: 10.1016/j.cca.2010.09.021
|
| 70 |
Péter Tátrai, Áron Somorácz, Enkhjargal Batmunkh, Peter Schirmacher, András Kiss, Zsuzsa Schaff, Péter Nagy, Ilona Kovalszky. Agrin and CD34 Immunohistochemistry for the Discrimination of Benign Versus Malignant Hepatocellular Lesions. American Journal of Surgical Pathology 2009; 33(6): 874 doi: 10.1097/PAS.0b013e318194b3ea
|
| 71 |
Yaofang Hu, Peng Zuo, Bang-Ce Ye. Label-free electrochemical impedance spectroscopy biosensor for direct detection of cancer cells based on the interaction between carbohydrate and lectin. Biosensors and Bioelectronics 2013; 43: 79 doi: 10.1016/j.bios.2012.11.028
|
| 72 |
J.-L. Payen, M.-A. Robic. Conduite à tenir devant une élévation des gamma-glutamyl-transférases. EMC - Hépatologie 2007; 2(4): 1 doi: 10.1016/S1155-1976(07)46233-7
|
| 73 |
Seo Young Park, Jiyou Han, Jong Bin Kim, Man-Gil Yang, Yoon Jun Kim, Hee-Joung Lim, Su Yeon An, Jong-Hoon Kim. Interleukin-8 is related to poor chemotherapeutic response and tumourigenicity in hepatocellular carcinoma. European Journal of Cancer 2014; 50(2): 341 doi: 10.1016/j.ejca.2013.09.021
|
| 74 |
Yi-Jun Zhang, Jie-Wei Chen, Xiao-Sheng He, Hui-Zhong Zhang, Yi-Hong Ling, Jia-Huai Wen, Wei-Hao Deng, Peng Li, Jing-Ping Yun, Dan Xie, Mu-Yan Cai. SATB2 is a Promising Biomarker for Identifying a Colorectal Origin for Liver Metastatic Adenocarcinomas. EBioMedicine 2018; 28: 62 doi: 10.1016/j.ebiom.2018.01.001
|
| 75 |
N Hasan, M Mukim, P Sharma, U. S. Baghel, M. Khalid. CURRENT UPDATES ON DIAGNOSTIC BIOMARKERS OF HEPATOCELLULAR CARCINOMA. INDIAN DRUGS 2019; 56(06): 7 doi: 10.53879/id.56.06.11625
|
| 76 |
Hira Hanif, Mukarram Jamat Ali, Ammu T Susheela, Iman Waheed Khan, Maria Alejandra Luna-Cuadros, Muzammil Muhammad Khan, Daryl Tan-Yeung Lau. Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma. World Journal of Gastroenterology 2022; 28(2): 216-229 doi: 10.3748/wjg.v28.i2.216
|
| 77 |
S M Morris, K T Carter, J Y Baek, A Koszarek, M M Yeh, S E Knoblaugh, W M Grady. TGF-β signaling alters the pattern of liver tumorigenesis induced by Pten inactivation. Oncogene 2015; 34(25): 3273 doi: 10.1038/onc.2014.258
|
| 78 |
YAN-JIE ZHAO, QIANG JU, GUAN-CHENG LI. Tumor markers for hepatocellular carcinoma. Molecular and Clinical Oncology 2013; 1(4): 593 doi: 10.3892/mco.2013.119
|
| 79 |
Shun-Jun Fu, Chao-Ying Qi, Wei-Kai Xiao, Shao-Qiang Li, Bao-Gang Peng, Li-Jian Liang. Glypican-3 is a potential prognostic biomarker for hepatocellular carcinoma after curative resection. Surgery 2013; 154(3): 536 doi: 10.1016/j.surg.2013.02.014
|
| 80 |
Ishfaq Hassan Mir, Shreyoshi Guha, Jajnasenee Behera, Chinnasamy Thirunavukkarasu. Targeting molecular signal transduction pathways in hepatocellular carcinoma and its implications for cancer therapy. Cell Biology International 2021; 45(11): 2161 doi: 10.1002/cbin.11670
|
| 81 |
Abdel‐Rahman N Zekri, Abeer A Bahnassy, Sabrin A Abdel‐Wahab, Medhat M Khafagy, Samah A Loutfy, Hessam Radwan, Sabry M Shaarawy. Expression of pro‐ and anti‐inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV‐genotype‐4. Journal of Gastroenterology and Hepatology 2009; 24(3): 416 doi: 10.1111/j.1440-1746.2008.05699.x
|
| 82 |
Agha Zeeshan Mirza. Multiplex NanoSPR Molecular Biosensor for Blood Cytokine Monitoring. Advanced Pharmaceutical Bulletin 2022; 12(3): 419 doi: 10.34172/apb.2022.046
|
| 83 |
Wei Wu, Dengfu Yao, Liwei Qiu, Xiaoxiao Gu, Xinhua Wu. Quantitative analysis of hepatoma-specific α-fetoprotein (HS-AFP) by a new mini-column affinity chromatography and its clinical value in diagnosis of hepatocellular carcinoma. The Chinese-German Journal of Clinical Oncology 2008; 7(3): 131 doi: 10.1007/s10330-007-0167-4
|
| 84 |
Han Chong Toh, Pei‐Jer Chen, Brian I. Carr, Jennifer J. Knox, Sharlene Gill, Peter Ansell, Evelyn M. McKeegan, Barry Dowell, Michelle Pedersen, Qin Qin, Jiang Qian, Frank A. Scappaticci, Justin L. Ricker, Dawn M. Carlson, Wei Peng Yong. Phase 2 trial of linifanib (ABT‐869) in patients with unresectable or metastatic hepatocellular carcinoma. Cancer 2013; 119(2): 380 doi: 10.1002/cncr.27758
|
| 85 |
Xiao-Fei Liu, Zhi-De Hu, Xiao-Cui Liu, Yuan Cao, Chun-Mei Ding, Cheng-Jin Hu. Diagnostic accuracy of serum glypican-3 for hepatocellular carcinoma: A systematic review and meta-analysis. Clinical Biochemistry 2014; 47(3): 196 doi: 10.1016/j.clinbiochem.2013.12.007
|
| 86 |
Nuerbieke Pulati, Zegao Zhang, Aireti Gulimilamu, Xiaoli Qi, Jie Yang. HPV16+‐miRNAs in cervical cancer and the anti‐tumor role played by miR‐5701. The Journal of Gene Medicine 2019; 21(11) doi: 10.1002/jgm.3126
|
| 87 |
Eray Yagmur, Mohamed Rizk, Sven Stanzel, Claus Hellerbrand, Frank Lammert, Christian Trautwein, Hermann E. Wasmuth, Axel M. Gressner. Elevation of endoglin (CD105) concentrations in serum of patients with liver cirrhosis and carcinoma. European Journal of Gastroenterology & Hepatology 2007; 19(9): 755 doi: 10.1097/MEG.0b013e3282202bea
|
| 88 |
Xue-En Liu, Liesbeth Desmyter, Chun-Fang Gao, Wouter Laroy, Sylviane Dewaele, Valerie Vanhooren, Ling Wang, Hui Zhuang, Nico Callewaert, Claude Libert, Roland Contreras, Cuiying Chen. N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus. Hepatology 2007; 46(5): 1426 doi: 10.1002/hep.21855
|
| 89 |
Yanli He, Haijun Lu, Lijuan Zhang. Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part A. Progress in Molecular Biology and Translational Science 2019; 162: 199 doi: 10.1016/bs.pmbts.2019.01.001
|
| 90 |
Chang-Can Li, Hua-Yu Yang, Yi-Lei Mao. Research progress and prospects of circulating tumor cells in hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International 2022; 21(6): 514 doi: 10.1016/j.hbpd.2022.07.001
|
| 91 |
Ke Zou, Jihang Ju, Hong Xie. Novel Tumor-associated Antigen of Hepatocellular Carcinoma Defined by Monoclonal Antibody E4-65. Acta Biochimica et Biophysica Sinica 2007; 39(5): 359 doi: 10.1111/j.1745-7270.2007.00288.x
|
| 92 |
Jose A. Nuevo-Gonzalez, Juan C. Cano-Ballesteros, Beatriz Lopez, Juan A. Andueza-Lillo, Luis Audibert. Alpha-Fetoprotein-Producing Extrahepatic Tumor: Clinical and Histopathological Significance of a Case. Journal of Gastrointestinal Cancer 2012; 43(S1): 28 doi: 10.1007/s12029-011-9310-0
|
| 93 |
Roli Saxena, Yogesh Kumar Chawla, Indu Verma, Jyotdeep Kaur. Interleukin-1 Polymorphism and Expression in Hepatitis B Virus-Mediated Disease Outcome in India. Journal of Interferon & Cytokine Research 2013; 33(2): 80 doi: 10.1089/jir.2012.0093
|
| 94 |
Ahmet Gurakar, Michelle Ma, Jacqueline Garonzik-Wang, Amy Kim, Robert A. Anders, Kiyoko Oshima, Christos Georgiades, Merve Gurakar, Shane Ottmann, Andrew M. Cameron, Benjamin Philosophe, Behnam Saberi. Clinicopathological Distinction of Low-AFP-Secreting vs. High-AFP-Secreting Hepatocellular Carcinomas. Annals of Hepatology 2018; 17(6): 1052 doi: 10.5604/01.3001.0012.7206
|
| 95 |
Umberto Cillo, Tommaso Giuliani, Marina Polacco, Luz Maria Herrero Manley, Gino Crivellari, Alessandro Vitale. Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation. World Journal of Gastroenterology 2016; 22(1): 232-252 doi: 10.3748/wjg.v22.i1.232
|
| 96 |
Natasa Pavlovic, Bhavna Rani, Pär Gerwins, Femke Heindryckx. Platelets as Key Factors in Hepatocellular Carcinoma. Cancers 2019; 11(7): 1022 doi: 10.3390/cancers11071022
|
| 97 |
Somaia Shehab-Eldeen, Abdallah Essa, Eman Arafat, Asmaa Sleem, Amal Alhosary, Ehab Darwish, Ali Essa, Omar Al-Omair, Emad Al-Khoufi, Abdulrhman Al Abdulqader, Ali Nada. Serum LINC00152 and UCA1 in HCV-Induced Hepatocellular Carcinoma: Clinical Significance and Prognostic Value. Biologics: Targets and Therapy 2023; : 137 doi: 10.2147/BTT.S433872
|
| 98 |
Issei Saeki, Takahiro Yamasaki, Norikazu Tanabe, Takuya Iwamoto, Toshihiko Matsumoto, Yohei Urata, Isao Hidaka, Tsuyoshi Ishikawa, Taro Takami, Naoki Yamamoto, Koichi Uchida, Shuji Terai, Isao Sakaida, Seung Up Kim. A New Therapeutic Assessment Score for Advanced Hepatocellular Carcinoma Patients Receiving Hepatic Arterial Infusion Chemotherapy. PLOS ONE 2015; 10(5): e0126649 doi: 10.1371/journal.pone.0126649
|
| 99 |
Jaromír Kotyza. Interleukin-8 (CXCL8) in Tumor Associated Non-Vascular Extracellular Fluids: Its Diagnostic and Prognostic Values. A Review. The International Journal of Biological Markers 2012; 27(3): 169 doi: 10.5301/JBM.2012.9261
|
| 100 |
Haiyan Lu, Hua Zhang, Yipo Xiao, Konstantin Chingin, Chao Dai, Feng Wei, Nanya Wang, Vladimir Frankevich, Vitaly Chagovets, Fan Zhou, Huanwen Chen. Comparative study of alterations in phospholipid profiles upon liver cancer in humans and mice. The Analyst 2020; 145(20): 6470 doi: 10.1039/D0AN01080D
|
| 101 |
Zheyu Zhou, Xiaoliang Xu, Yang Liu, Qiaoyu Liu, Wenjie Zhang, Kun Wang, Jincheng Wang, Yin Yin. Liquid Biopsies. Methods in Molecular Biology 2023; 2695: 213 doi: 10.1007/978-1-0716-3346-5_14
|
| 102 |
Amr Abdel-Moety, Nahed Baddour, Perihan Salem, Hesham El-Tobgy, Assem El-Shendidi. SQSTM1 Expression in Hepatocellular Carcinoma and Relation to Tumor Recurrence After Radiofrequency Ablation. Journal of Clinical and Experimental Hepatology 2022; 12(3): 774 doi: 10.1016/j.jceh.2021.12.001
|
| 103 |
Lior Charach, Lior Zusmanovitch, Gideon Charach. Hepatocellular Carcinoma. Part 2: Clinical Presentation and Diagnosis. EMJ Hepatology 2017; : 81 doi: 10.33590/emjhepatol/10311703
|
| 104 |
Kai Zhu, Zhi Dai, Jian Zhou. Biomarkers for hepatocellular carcinoma: progression in early diagnosis, prognosis, and personalized therapy. Biomarker Research 2013; 1(1) doi: 10.1186/2050-7771-1-10
|
| 105 |
Christoph Roderburg, Jhenee Bubenzer, Michael Spannbauer, Nicole do O, Andreas Mahnken, Tom Ludde, Christian Trautwein, Jens J Tischendorf. Long-term survival of a HCC-patient with severe liver dysfunction treated with sorafenib. World Journal of Hepatology 2010; 2(6): 239-242 doi: 10.4254/wjh.v2.i6.239
|
| 106 |
Mohamed S. Othman, Ahmed M. Aref, Amal A. Mohamed, Wesam A. Ibrahim. Serum Levels of Interleukin-6 and Interleukin-10 as Biomarkers for Hepatocellular Carcinoma in Egyptian Patients. ISRN Hepatology 2013; 2013: 1 doi: 10.1155/2013/412317
|
| 107 |
Zheng Guo, Jing Wang, Li Li, Rong Liu, Jin Fang, Bin Tie. Value of miR-1271 and glypican-3 in evaluating the prognosis of patients with hepatocellular carcinoma after transcatheter arterial chemoembolization. World Journal of Clinical Cases 2020; 8(16): 3493-3502 doi: 10.12998/wjcc.v8.i16.3493
|
| 108 |
Hanan H. Soliman, Hala Nagy, Nesreen Kotb, Mohamed A. Alm El-Din. The role of chemokine CC ligand 20 in patients with liver cirrhosis and hepatocellular carcinoma. The International Journal of Biological Markers 2012; 27(2): 125 doi: 10.5301/JBM.2012.9097
|
| 109 |
Qing-Qin Hao, Guang-Yi Chen, Jun-Hua Zhang, Jia-He Sheng, Yun Gao. Diagnostic value of long noncoding RNAs for hepatocellular carcinoma. Medicine 2017; 96(28): e7496 doi: 10.1097/MD.0000000000007496
|
| 110 |
Janio Szklaruk, Eddie K. Abdalla, Ahmed O. Kaseb, Sunil Krishnan. Oncologic Imaging: A Multidisciplinary Approach. 2012; : 95 doi: 10.1016/B978-1-4377-2232-1.00009-7
|
| 111 |
Manjula Kiran, Yogesh Kumar Chawla, Jyotdeep Kaur. Glutathione-S-Transferase and Microsomal Epoxide Hydrolase Polymorphism and Viral-Related Hepatocellular Carcinoma Risk in India. DNA and Cell Biology 2008; 27(12): 687 doi: 10.1089/dna.2008.0805
|
| 112 |
Petra Thulin, Gunnar Nordahl, Marcus Gry, Getnet Yimer, Eleni Aklillu, Eyasu Makonnen, Getachew Aderaye, Lars Lindquist, C. Mikael Mattsson, Björn Ekblom, Daniel J. Antoine, B. Kevin Park, Stig Linder, Alison H. Harrill, Paul B. Watkins, Björn Glinghammar, Ina Schuppe‐Koistinen. Keratin‐18 and microRNA‐122 complement alanine aminotransferase as novel safety biomarkers for drug‐induced liver injury in two human cohorts. Liver International 2014; 34(3): 367 doi: 10.1111/liv.12322
|
| 113 |
Ming‐Chao Tsai, Jing‐Houng Wang, Chao‐Hung Hung, Kwong‐Ming Kee, Yi‐Hao Yen, Chuan‐Mo Lee, Tsung‐Hui Hu, Chien‐Hung Chen, Sheng‐Nan Lu. Favorable α‐fetoprotein decrease as a prognostic surrogate in patients with hepatocellular carcinoma after radiofrequency ablation. Journal of Gastroenterology and Hepatology 2010; 25(3): 605 doi: 10.1111/j.1440-1746.2009.06115.x
|
| 114 |
Nabil Mohie Abdel-Hamid, M. M. Abouzied, M. H. Nazmy, M. A. Fawzy, A. S. Gerges. A suggested guiding panel of seromarkers for efficient discrimination between primary and secondary human hepatocarcinoma. Tumor Biology 2016; 37(2): 2539 doi: 10.1007/s13277-015-4025-7
|
| 115 |
Wenling Zhang, Yumei Huang, Jian Xu. Clinical Molecular Diagnostics. 2021; : 261 doi: 10.1007/978-981-16-1037-0_21
|
| 116 |
Mekky Mohammed Abouzied, Heba M. Eltahir, Michael Atef Fawzy, Nabil Mohie Abdel-Hamid, Amany Saber Gerges, Hesham Mohmoud El-Ibiari, Maiiada Hassan Nazmy. Estimation of Leucine Aminopeptidase and 5-Nucleotidase Increases Alpha-Fetoprotein Sensitivity in Human Hepatocellular Carcinoma Cases. Asian Pacific Journal of Cancer Prevention 2015; 16(3): 959 doi: 10.7314/APJCP.2015.16.3.959
|
| 117 |
Ya-Wen Teng, Mihai G. Mehedint, Timothy A. Garrow, Steven H. Zeisel. Deletion of Betaine-Homocysteine S-Methyltransferase in Mice Perturbs Choline and 1-Carbon Metabolism, Resulting in Fatty Liver and Hepatocellular Carcinomas. Journal of Biological Chemistry 2011; 286(42): 36258 doi: 10.1074/jbc.M111.265348
|
| 118 |
Manar Mahmoud El-Tonsy, Hesham Mohammed Hussein, Thanaa El-Sayed Helal, Rania Ayman Tawfik, Khalid Mohamed Koriem, Hend Mohamed Hussein. Schistosoma mansoni infection: Is it a risk factor for development of hepatocellular carcinoma?. Acta Tropica 2013; 128(3): 542 doi: 10.1016/j.actatropica.2013.07.024
|
| 119 |
Roli Saxena, Yogesh Kumar Chawla, Indu Verma, Jyotdeep Kaur. Effect of IL-12B, IL-2, TGF-β1, and IL-4 Polymorphism and Expression on Hepatitis B Progression. Journal of Interferon & Cytokine Research 2014; 34(2): 117 doi: 10.1089/jir.2013.0043
|
| 120 |
Yasunori Matsuda, Yoko Yamagiwa, Koji Fukushima, Yoshiyuki Ueno, Tooru Shimosegawa. Expression of galectin‐3 involved in prognosis of patients with hepatocellular carcinoma. Hepatology Research 2008; 38(11): 1098 doi: 10.1111/j.1872-034X.2008.00387.x
|
| 121 |
Ying Liu, Ke Li, Zhonghai Ren, Shenglei Li, Hongyan Zhang, Qingxia Fan. Clinical Implication of Elevated Human Cervical Cancer Oncogene-1 Expression in Esophageal Squamous Cell Carcinoma. Journal of Histochemistry & Cytochemistry 2012; 60(7): 512 doi: 10.1369/0022155412444437
|
| 122 |
Sachiko Ogasawara, Masamichi Nakayama, Jun Akiba, Hironori Kusano, Hirohisa Yano. Effect of sorafenib on des-γ-carboxyprothrombin secretion by a human hepatocellular carcinoma cell line. Oncology Letters 2017; 14(2): 2170 doi: 10.3892/ol.2017.6451
|
| 123 |
Münevver Demir, Friederike Grünewald, Sonja Lang, Christoph Schramm, Andrea Bowe, Vera Mück, Fabian Kütting, Tobias Goeser, Hans-Michael Steffen. Elevated liver fibrosis index FIB-4 is not reliable for HCC risk stratification in predominantly non-Asian CHB patients. Medicine 2016; 95(38): e4602 doi: 10.1097/MD.0000000000004602
|
| 124 |
Hala M. Abdul-Al, Hala R. Makhlouf, Guanghua Wang, Zachary D. Goodman. Glypican-3 expression in benign liver tissue with active hepatitis C: implications for the diagnosis of hepatocellular carcinoma. Human Pathology 2008; 39(2): 209 doi: 10.1016/j.humpath.2007.06.004
|
| 125 |
M. A. Abdelwa, M. M. Elbedew, A. M. Amin, A. K. Tawfik. Serum Endoglin and IL-6 Levels as Complementary Diagnostic Biomarkers for Hepatocellular Carcinoma in Egyptian Liver Cirrhosis Patients. Research Journal of Immunology 2016; 10(1): 1 doi: 10.3923/rji.2017.1.7
|
| 126 |
Muhammad Usman Ghani, Asma Haque, Muhammad Sarfaraz Iqbal, Usman Ali Ashfaq, Muhammad Shareef Mausood, Muhammad Qasim, Shah Jahan, Farwa Batool Shamsi, Muhammad Yousaf. TGF-β1 rs1800469 gene polymorphism in the development of cirrhosis & hepatocellular carcinoma in Pakistani HCV patients. Future Virology 2019; 14(10): 663 doi: 10.2217/fvl-2019-0047
|
| 127 |
Sahar A. Helmy, Mohamed El-Mesery, Amro El-Karef, Laila A. Eissa, Amal M. El Gayar. Thymoquinone upregulates TRAIL/TRAILR2 expression and attenuates hepatocellular carcinoma in vivo model. Life Sciences 2019; 233: 116673 doi: 10.1016/j.lfs.2019.116673
|
| 128 |
Joham Choque-Velasquez, Roberto Colasanti, Danil A. Kozyrev, Szymon Baluszek, Sajjad Muhammad, Juha Hernesniemi. Pediatric Neurosurgery for Clinicians. 2022; : 345 doi: 10.1007/978-3-030-80522-7_23
|
| 129 |
Dincer Ozgor, Emrah Otan. HCC and Tumor Biomarkers: Does One Size Fits All?. Journal of Gastrointestinal Cancer 2020; 51(4): 1122 doi: 10.1007/s12029-020-00485-x
|
| 130 |
Meng Zhang, Lin Wang, Haiping Zhang, Juan Cong, Lijuan Zhang. Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part A. Progress in Molecular Biology and Translational Science 2019; 162: 349 doi: 10.1016/bs.pmbts.2018.12.008
|
| 131 |
Fundamentals of Cancer Detection, Treatment, and Prevention. 2022; : 247 doi: 10.1002/9783527838561.ch10
|
| 132 |
Zahra Heidari, Bita Moudi. Application of Tumor Biomarkers as Screening Tools in Early Detection of Hepatocellular Carcinoma. Gene, Cell and Tissue 2015; 2(4) doi: 10.17795/gct-33012
|
| 133 |
ZHENHAI ZHANG, CHENGKUN QIN, YAGUANG WU, ZHONGXUE SU, GUOZHE XIAN, BO HU. CCR9 as a prognostic marker and therapeutic target in hepatocellular carcinoma. Oncology Reports 2014; 31(4): 1629 doi: 10.3892/or.2014.2998
|
| 134 |
Qianwei Ye, Sunbin Ling, Shusen Zheng, Xiao Xu. Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA. Molecular Cancer 2019; 18(1) doi: 10.1186/s12943-019-1043-x
|
| 135 |
Kewal K. Jain. Applications of Biotechnology in Oncology. 2014; : 87 doi: 10.1007/978-1-4614-9245-0_5
|
| 136 |
Zhizhou Kuang, Ruochun Huang, Zhimin Yang, Zhiqiang Lv, Xinyan Chen, Fuping Xu, Yu-Hua Yi, Jian Wu, Ruo-Pan Huang. Quantitative screening of serum protein biomarkers by reverse phase protein arrays. Oncotarget 2018; 9(66): 32624 doi: 10.18632/oncotarget.25976
|
| 137 |
Lamiaa N. Hammad, Sahar M. Abdelraouf, Fetouh S. Hassanein, Walid A. Mohamed, Mona F. Schaalan. Circulating IL-6, IL-17 and vitamin D in hepatocellular carcinoma: Potential biomarkers for a more favorable prognosis?. Journal of Immunotoxicology 2013; 10(4): 380 doi: 10.3109/1547691X.2012.758198
|
| 138 |
Setor K. Kunutsor, Tanefa A. Apekey, Mieke Van Hemelrijck, Giliola Calori, Gianluca Perseghin. Gamma glutamyltransferase, alanine aminotransferase and risk of cancer: Systematic review and meta‐analysis. International Journal of Cancer 2015; 136(5): 1162 doi: 10.1002/ijc.29084
|
| 139 |
Miner Hu, Xiaojun Xia, Lichao Chen, Yunpeng Jin, Zhenhua Hu, Shudong Xia, Xudong Yao. Emerging biomolecules for practical theranostics of liver hepatocellular carcinoma. Annals of Hepatology 2023; 28(6): 101137 doi: 10.1016/j.aohep.2023.101137
|
| 140 |
Roli Saxena, Yogesh Kumar Chawla, Indu Verma, Jyotdeep Kaur. IL‐6(−572/−597) polymorphism and expression in HBV disease chronicity in an Indian population. American Journal of Human Biology 2014; 26(4): 549 doi: 10.1002/ajhb.22562
|
| 141 |
Manar Obada, Marwa Helal, Tarek Abd El Hakeem, Hassan Abd El Hady, Ahmed Raouf. The value of serum neopterin as a potential marker of hepatocellular carcinoma. Egyptian Liver Journal 2013; 3(3): 97 doi: 10.1097/01.ELX.0000429700.41933.20
|
| 142 |
Thanaa El.A. Helal, Nehal A. Radwan, Zeinab Abdel Kader, Noha A.H. Helmy, Shimaa Y.A. Hammad. Role of alpha methylacyl-coenzyme A racemase in differentiating hepatocellular carcinoma from dysplastic and nondysplastic liver cell lesions. Annals of Diagnostic Pathology 2012; 16(5): 330 doi: 10.1016/j.anndiagpath.2012.01.003
|
| 143 |
Kwang Hoe Kim, Jin Young Kim, Jong Shin Yoo. Mass spectrometry analysis of glycoprotein biomarkers in human blood of hepatocellular carcinoma. Expert Review of Proteomics 2019; 16(7): 553 doi: 10.1080/14789450.2019.1626235
|
| 144 |
Iman A. Abd El Gawad, Ghada I. Mossallam, Noha H. Radwan, Heba M. Elzawahry, Niveen M. Elhifnawy. Comparing Prothrombin induced by vitamin K absence-II (PIVKA-II) with the oncofetal proteins Glypican-3, Alpha feto protein and Carcinoembryonic antigen in diagnosing hepatocellular carcinoma among Egyptian patients. Journal of the Egyptian National Cancer Institute 2014; 26(2): 79 doi: 10.1016/j.jnci.2014.01.001
|
| 145 |
Jin Un Kim, Mohamed I F Shariff, Mary M E Crossey, Maria Gomez-Romero, Elaine Holmes, I Jane Cox, Haddy K S Fye, Ramou Njie, Simon D Taylor-Robinson. Hepatocellular carcinoma: Review of disease and tumor biomarkers. World Journal of Hepatology 2016; 8(10): 471-484 doi: 10.4254/wjh.v8.i10.471
|
| 146 |
Zhicheng Yao, Changchang Jia, Yan Tai, Hao Liang, Zhaozhong Zhong, Zhiyong Xiong, Meihai Deng, Qi Zhang. Serum exosomal long noncoding RNAs lnc-FAM72D-3 and lnc-EPC1-4 as diagnostic biomarkers for hepatocellular carcinoma. Aging 2020; 12(12): 11843 doi: 10.18632/aging.103355
|
| 147 |
Quynh Hoa Tran, Van Gio Nguyen, Cong Manh Tran, Minh Nam Nguyen. Down-regulation of solute carrier family 10 member 1 is associated with early recurrence and poorer prognosis of hepatocellular carcinoma. Heliyon 2021; 7(3): e06463 doi: 10.1016/j.heliyon.2021.e06463
|
| 148 |
Issei Saeki, Takahiro Yamasaki, Masaki Maeda, Takuro Hisanaga, Takuya Iwamoto, Toshihiko Matsumoto, Isao Hidaka, Tsuyoshi Ishikawa, Taro Takami, Isao Sakaida. Evaluation of the “assessment for continuous treatment with hepatic arterial infusion chemotherapy” scoring system in patients with advanced hepatocellular carcinoma. Hepatology Research 2018; 48(3) doi: 10.1111/hepr.12932
|
| 149 |
Keun Na, Eun‐Young Lee, Hyoung‐Joo Lee, Kwang‐Youl Kim, Hanna Lee, Seul‐Ki Jeong, An‐Sung Jeong, Sang Yun Cho, Sun A. Kim, Si Young Song, Kyung Sik Kim, Sung Won Cho, Hoguen Kim, Young‐Ki Paik. Human plasma carboxylesterase 1, a novel serologic biomarker candidate for hepatocellular carcinoma. PROTEOMICS 2009; 9(16): 3989 doi: 10.1002/pmic.200900105
|
| 150 |
Jari Intra, Maria-Elisa Perotti, Giulio Pavesi, David Horner. Comparative and phylogenetic analysis of α-l-fucosidase genes. Gene 2007; 392(1-2): 34 doi: 10.1016/j.gene.2006.11.002
|
| 151 |
Michael J. Reiter, Justin E. Costello, Ryan B. Schwope, Christopher J. Lisanti, Michael B. Osswald. Review of Commonly Used Serum Tumor Markers and Their Relevance for Image Interpretation. Journal of Computer Assisted Tomography 2015; 39(6): 825 doi: 10.1097/RCT.0000000000000297
|
| 152 |
Fabio Grizzi, Barbara Franceschini, Cody Hamrick, Eldo E Frezza, Everardo Cobos, Maurizio Chiriva-Internati. Usefulness of cancer-testis antigens as biomarkers for the diagnosis and treatment of hepatocellular carcinoma. Journal of Translational Medicine 2007; 5(1) doi: 10.1186/1479-5876-5-3
|
| 153 |
Franck Chiappini. Circulating Tumor Cells Measurements in Hepatocellular Carcinoma. International Journal of Hepatology 2012; 2012: 1 doi: 10.1155/2012/684802
|
| 154 |
Yan Zhou, Beili Wang, Jiong Wu, Chunyan Zhang, Yiwen Zhou, XinRong Yang, Jian Zhou, Wei Guo, Jia Fan. Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2526-4
|
| 155 |
Johannes C. Melms, Rohit Thummalapalli, Kristin Shaw, Huihui Ye, Leo Tsai, Rupal S. Bhatt, Benjamin Izar. Alpha-fetoprotein (AFP) as tumor marker in a patient with urothelial cancer with exceptional response to anti-PD-1 therapy and an escape lesion mimic. Journal for ImmunoTherapy of Cancer 2018; 6(1) doi: 10.1186/s40425-018-0394-y
|
| 156 |
Amal Saad-Hussein, Safia Beshir, Mona M. Taha, Eman M. Shahy, Weam Shaheen, Ebtesam A. Abdel-Shafy, Eman Thabet. Early prediction of liver carcinogenicity due to occupational exposure to pesticides. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2019; 838: 46 doi: 10.1016/j.mrgentox.2018.12.004
|
| 157 |
Antonio Lacalamita, Grazia Serino, Ester Pantaleo, Alfonso Monaco, Nicola Amoroso, Loredana Bellantuono, Emanuele Piccinno, Viviana Scalavino, Francesco Dituri, Sabina Tangaro, Roberto Bellotti, Gianluigi Giannelli. Artificial Intelligence and Complex Network Approaches Reveal Potential Gene Biomarkers for Hepatocellular Carcinoma. International Journal of Molecular Sciences 2023; 24(20): 15286 doi: 10.3390/ijms242015286
|
| 158 |
Tim Nagel, Florentine Klaus, Ines Gil Ibanez, Henning Wege, Ansgar Lohse, Bernd Meyer. Fast and facile analysis of glycosylation and phosphorylation of fibrinogen from human plasma—correlation with liver cancer and liver cirrhosis. Analytical and Bioanalytical Chemistry 2018; 410(30): 7965 doi: 10.1007/s00216-018-1418-7
|
| 159 |
Ahmed M. Tahon, Magdy Z. El-Ghanam, Samy Zaky, Tarek Mostafa Emran, Ali M. Bersy, Fathiya El-Raey, Elsayed A.Z., Amr M. El Kharsawy, Dina Johar. Significance of Glypican-3 in Early Detection of Hepatocellular Carcinoma in Cirrhotic Patients. Journal of Gastrointestinal Cancer 2019; 50(3): 434 doi: 10.1007/s12029-018-0095-2
|
| 160 |
Mohammad Heiat, Masoud Negahdary. Sensitive diagnosis of alpha-fetoprotein by a label free nanoaptasensor designed by modified Au electrode with spindle-shaped gold nanostructure. Microchemical Journal 2019; 148: 456 doi: 10.1016/j.microc.2019.05.004
|
| 161 |
Eric Waidely, Abdul-Rahman Obaid Al-Yuobi, A. S. Bashammakh, Mohammad S. El-Shahawi, Roger M. Leblanc. Serum protein biomarkers relevant to hepatocellular carcinoma and their detection. The Analyst 2016; 141(1): 36 doi: 10.1039/C5AN01884F
|
| 162 |
Beenish Rahat, Manjula Kiran, Roli Saxena, Yogesh K Chawla, Rati R Sharma, Jyotdeep Kaur. Microsomal Epoxide Hydrolase Polymorphisms and Haplotypes as Determinants of Hepatitis B Virusand Hepatitis C Virus-related Liver Disease in Indian Population. Journal of Clinical and Experimental Hepatology 2012; 2(2): 104 doi: 10.1016/S0973-6883(12)60097-8
|
| 163 |
Xiaowei Chi, Liejun Jiang, Yulin Yuan, Xinyan Huang, Xuemei Yang, Steven Hochwald, Jie Liu, Huayi Huang. A comparison of clinical pathologic characteristics between alpha-fetoprotein negative and positive hepatocellular carcinoma patients from Eastern and Southern China. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02279-w
|
| 164 |
Toshiro Masuda, Toru Beppu, Kei Horino, Hiroyuki Komori, Hiromitsu Hayashi, Hirohisa Okabe, Ryu Otao, Hasita Horlad, Takatoshi Ishiko, Hiroshi Takamori, Ken Kikuchi, Hideo Baba. Preoperative tumor marker doubling time is a useful predictor of recurrence and prognosis after hepatic resection of hepatocellular carcinoma. Journal of Surgical Oncology 2010; 102(5): 490 doi: 10.1002/jso.21451
|
| 165 |
|
| 166 |
Shelli M. Morris, Ji Yeon Baek, Amanda Koszarek, Samornmas Kanngurn, Sue E. Knoblaugh, William M. Grady. Transforming growth factor-beta signaling promotes hepatocarcinogenesis induced by p53 loss. Hepatology 2012; 55(1): 121 doi: 10.1002/hep.24653
|
| 167 |
Mohammed A. Eldesouky, Molham A. Elbakary, Osama E. Shalaby, Mohamed M. Shareef. Orbital Metastasis From Hepatocellular Carcinoma. Ophthalmic Plastic & Reconstructive Surgery 2014; 30(4): e78 doi: 10.1097/IOP.0b013e31829f3a57
|
| 168 |
Giuseppe Gazzana, Jürgen Borlak. Mapping of the Serum Proteome of Hepatocellular Carcinoma Induced by Targeted Overexpression of Epidermal Growth Factor to Liver Cells of Transgenic Mice. Journal of Proteome Research 2008; 7(3): 928 doi: 10.1021/pr070462c
|
| 169 |
Yuan Tian, Hui Zhang. Characterization of disease‐associated N‐linked glycoproteins. PROTEOMICS 2013; 13(3-4): 504 doi: 10.1002/pmic.201200333
|
| 170 |
Binghua Li, Wendu Feng, Ouyang Luo, Tiancheng Xu, Yajuan Cao, Hongyan Wu, Decai Yu, Yitao Ding. Development and Validation of a Three-gene Prognostic Signature for Patients with Hepatocellular Carcinoma. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-04811-5
|
| 171 |
|
| 172 |
Mary Levy, Anand Trivedi, Jun Zhang, Lili Miles, Aras N. Mattis, Grace E. Kim, Charles Lassman, Robert A. Anders, Joseph Misdraji, Lisa M. Yerian, Haodong Xu, Deepti Dhall, Hanlin L. Wang. Expression of glypican-3 in undifferentiated embryonal sarcoma and mesenchymal hamartoma of the liver. Human Pathology 2012; 43(5): 695 doi: 10.1016/j.humpath.2011.06.016
|
| 173 |
Hu Zhao, Yaojun Li, Ye Hu. Nanotechnologies in Glycoproteomics. Clinical Proteomics 2014; 11(1) doi: 10.1186/1559-0275-11-21
|
| 174 |
Yomna A. Elleithi, Amal M. El-Gayar, Mohamed N. Amin. Simvastatin Induces Apoptosis And Suppresses Hepatocellular Carcinoma Induced In Rats. Applied Biochemistry and Biotechnology 2023; 195(3): 1656 doi: 10.1007/s12010-022-04203-0
|
| 175 |
Noboru Mitsuhashi, Souichi Kobayashi, Tomoko Doki, Fumio Kimura, Hiroaki Shimizu, Hiroyuki Yoshidome, Masayuki Ohtsuka, Atsushi Kato, Hideyuki Yoshitomi, Satoshi Nozawa, Katsunori Furukawa, Dan Takeuchi, Kosuke Suda, Seiki Miura, Masaru Miyazaki. Clinical significance of α‐fetoprotein: involvement in proliferation, angiogenesis, and apoptosis of hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2008; 23(7pt2) doi: 10.1111/j.1440-1746.2008.05340.x
|
| 176 |
Hoang Van Tong, Pham Van Dung, Nguyen Thi Mong Diep, Nguyen Linh Toan. Hepatocellular Carcinoma - Challenges and Opportunities of a Multidisciplinary Approach. 2022; doi: 10.5772/intechopen.98483
|
| 177 |
Tudor Mocan, André L. Simão, Rui E. Castro, Cecília M. P. Rodrigues, Artur Słomka, Bingduo Wang, Christian Strassburg, Aliona Wöhler, Arnulf G. Willms, Miroslaw Kornek. Liquid Biopsies in Hepatocellular Carcinoma: Are We Winning?. Journal of Clinical Medicine 2020; 9(5): 1541 doi: 10.3390/jcm9051541
|
| 178 |
Tarek D. Hussein. Serological tumor markers of hepatocellular carcinoma: a meta-analysis. The International Journal of Biological Markers 2015; 30(1): 32 doi: 10.5301/jbm.5000119
|
| 179 |
Amy K. Kim, James P. Hamilton, Selena Y. Lin, Ting-Tsung Chang, Hie-Won Hann, Chi-Tan Hu, Yue Lou, Yih-Jyh Lin, Terence P. Gade, Grace Park, Harry Luu, Tai-Jung Lee, Jeremy Wang, Dion Chen, Michael G. Goggins, Surbhi Jain, Wei Song, Ying-Hsiu Su. Urine DNA biomarkers for hepatocellular carcinoma screening. British Journal of Cancer 2022; 126(10): 1432 doi: 10.1038/s41416-022-01706-9
|
| 180 |
Qianyun Zhang, Xu Wang, Zhenjia Li, Jin-Ming Lin. Evaluation of α-fetoprotein (AFP) in human serum by chemiluminescence enzyme immunoassay with magnetic particles and coated tubes as solid phases. Analytica Chimica Acta 2009; 631(2): 212 doi: 10.1016/j.aca.2008.10.042
|
| 181 |
Hua Yang, Fuxia Xiong, Ruizhao Qi, Zhenwen Liu, Ming Lin, Jingan Rui, Jing Su, Rouli Zhou. LAPTM4B‐35 is a novel prognostic factor of hepatocellular carcinoma. Journal of Surgical Oncology 2010; 101(5): 363 doi: 10.1002/jso.21489
|
| 182 |
Qi Peng, Gao Chunfang, Fang Meng, Ji Qiang, Zhao Yunpeng, Liu Yan, Sun Xiaojuan. Establishment of a real-time PCR for quantifying transforming growth factor beta1 in blood of hepatocellular carcinoma patients. Journal of Medical Colleges of PLA 2008; 23(4): 228 doi: 10.1016/S1000-1948(08)60047-7
|
| 183 |
JING ZHU, FENG JIANG, HONG-BING NI, MING-BING XIAO, BU-YOU CHEN, WEN-KAI NI, CUI-HUA LU, RUN-ZHOU NI. Combined analysis of serum γ-glutamyl transferase isoenzyme II, α-L-fucosidase and α-fetoprotein detected using a commercial kit in the diagnosis of hepatocellular carcinoma. Experimental and Therapeutic Medicine 2013; 5(1): 89 doi: 10.3892/etm.2012.783
|
| 184 |
Hyejung Cha, Eun Jung Lee, Jinsil Seong. Multi-analyte analysis of cytokines that predict outcomes in patients with hepatocellular carcinoma treated with radiotherapy. World Journal of Gastroenterology 2017; 23(11): 2077-2085 doi: 10.3748/wjg.v23.i11.2077
|
| 185 |
Sejong Chun, Su Yeon Rhie, Chang-Seok Ki, Jee Eun Kim, Hyung-Doo Park. Evaluation of alpha-fetoprotein as a screening marker for hepatocellular carcinoma in hepatitis prevalent areas. Annals of Hepatology 2015; 14(6): 881 doi: 10.5604/16652681.1171776
|
| 186 |
|
| 187 |
Sreyashi Das, Ram Devireddy, Manas Ranjan Gartia. Surface Plasmon Resonance (SPR) Sensor for Cancer Biomarker Detection. Biosensors 2023; 13(3): 396 doi: 10.3390/bios13030396
|
| 188 |
Matthew R. Pincus, Philip M. Tierno, Maly Fenelus, Wilbur B. Bowne, Martin H. Bluth. Henry's Clinical Diagnosis and Management by Laboratory Methods. 2011; : 296 doi: 10.1016/B978-1-4377-0974-2.00021-X
|
| 189 |
Zhenyu Zhang, Jinfeng Zhu, Yansong Huang, Weibing Li, Hongqiu Cheng. MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway. Diagnostic Pathology 2018; 13(1) doi: 10.1186/s13000-018-0763-3
|
| 190 |
Hanaa H. Ahmed, Wafaa Gh. Shousha, Aziza B. Shalby, Hatem A. El-Mezayen, Nora N. Ismaiel, Nadia S. Mahmoud. Curcumin: a unique antioxidant offers a multimechanistic approach for management of hepatocellular carcinoma in rat model. Tumor Biology 2015; 36(3): 1667 doi: 10.1007/s13277-014-2767-2
|
| 191 |
Ka Yin Lui, Hao-ran Peng, Jin-rong Lin, Chun-hui Qiu, Hu-an Chen, Rong-dang Fu, Chang-jie Cai, Min-qiang Lu. Pseudogene integrator complex subunit 6 pseudogene 1 (INTS6P1) as a novel plasma-based biomarker for hepatocellular carcinoma screening. Tumor Biology 2016; 37(1): 1253 doi: 10.1007/s13277-015-3899-8
|
| 192 |
Hammad Zafar, Mamoon Ur Rashid, Deepika Sarvepalli, Muzammil Muhammad Khan, Bayarmaa Mandzhieva, Akriti Gupta Jain, Rima Shobar, Anum Jalil, Sarfraz Ahmad. Phytochemicals Targeting Tumor Microenvironment in Gastrointestinal Cancers. 2020; : 287 doi: 10.1007/978-3-030-48405-7_13
|
| 193 |
Meng Qiao, Arthur B. Pardee. Biomarkers, regerons, and pathways to lethal cancer. Journal of Cellular Biochemistry 2007; 102(5): 1076 doi: 10.1002/jcb.21534
|
| 194 |
Giovanni Centini, Lucia Rosignoli, Elisa Faldini, Francesco Calonaci, Felice Petraglia. Medicina dell’età prenatale. 2008; : 209 doi: 10.1007/978-88-470-0688-1_12
|
| 195 |
Rehab A. Mohamed, Hend M. Maghraby, Eman M. Abd El Salam, Hala M. Nageb, Eman E. Ahmad, Nagwa A. Mohamed. Evaluation of serum endoglin as noninvasive marker in hepatocellular carcinoma. The Egyptian Journal of Internal Medicine 2015; 27(1): 15 doi: 10.4103/1110-7782.155832
|
| 196 |
Hanaa H. Ahmed, Hanaa M. Rady, Soheir E. Kotob. Evidences for the antitumor potentiality of Hemimycale arabica and Negombata magnifica mesohyls in hepatocellular carcinoma rat model. Medicinal Chemistry Research 2018; 27(5): 1538 doi: 10.1007/s00044-018-2171-3
|
| 197 |
Andreea Cioca, Anca Cimpean, Raluca Ceausu, Ana-Maria Fit, Teodor Zaharie, Nadim Al-Hajjar, Vlad Puia, Marius Raica. Crosstalk between EGFR and p53 in Hepatocellular Carcinoma. Asian Pacific Journal of Cancer Prevention 2014; 15(19): 8069 doi: 10.7314/APJCP.2014.15.19.8069
|
| 198 |
ZHIKUN LIU, QI LING, JIANGUO WANG, HAIYANG XIE, XIAO XU, SHUSEN ZHENG. Annexin A2 is not a good biomarker for hepatocellular carcinoma in cirrhosis. Oncology Letters 2013; 6(1): 125 doi: 10.3892/ol.2013.1337
|
| 199 |
Yamini Sabherwal, Vicki L. Rothman, Ronnie T.P. Poon, George P. Tuszynski. Clinical significance of serum angiocidin levels in hepatocellular carcinoma. Cancer Letters 2007; 251(1): 28 doi: 10.1016/j.canlet.2006.10.023
|
| 200 |
Swarupa Ghosh, Sandhya Rekha Dungdung, Somsubhra Thakur Choudhury, Somsuta Chakraborty, Nirmalendu Das. Mitochondria protection with ginkgolide B-loaded polymeric nanocapsules prevents diethylnitrosamine-induced hepatocarcinoma in rats. Nanomedicine 2014; 9(3): 441 doi: 10.2217/nnm.13.56
|
| 201 |
Rafael Miret, Amir Riaz, Sikandar Khan, Asad Ur Rahman. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. 2022; : 275 doi: 10.1016/B978-0-323-99283-1.00010-0
|
| 202 |
Zhixiang Zhang, Hanhan Bao, Haitao Yu, Xinxin Li. ng/ml-Level Alpha-Fetoprotein Immuno-Detection with Torsion-Mode Cantilever Sensors for Early-Stage Heptocellular Carcinoma Diagnosis. TRANSDUCERS 2007 - 2007 International Solid-State Sensors, Actuators and Microsystems Conference 2007; : 1785 doi: 10.1109/SENSOR.2007.4300500
|
| 203 |
Ning Gan, Ling Hua Meng, Feng Wang. Amperometric immunosensor for α-fetoprotein antigen in human serum based on co-immobilizing dinuclear copper complex and gold nanoparticle doped chitosan film. Journal of Physics: Conference Series 2009; 188: 012047 doi: 10.1088/1742-6596/188/1/012047
|
| 204 |
Fayza A. Rahamtalla, Mohammed S. M. Abdalla, Salma B. M. Mudawi, Mohammed A. H. Kheir Elsid, Iman M. Shammat. Estimation of telomerase, AFP, and AFP-L3 levels in Sudanese patients with hepatocellular carcinoma and chronic liver diseases. Comparative Clinical Pathology 2018; 27(5): 1133 doi: 10.1007/s00580-018-2709-2
|
| 205 |
HIROKI NISHIKAWA, AKIRA ARIMOTO, TOMOKO WAKASA, RYUICHI KITA, TORU KIMURA, YUKIO OSAKI. Effect of transcatheter arterial chemoembolization prior to surgical resection for hepatocellular carcinoma. International Journal of Oncology 2013; 42(1): 151 doi: 10.3892/ijo.2012.1711
|
| 206 |
Xu Yu, He-Shun Xia, Zuo-Dong Sun, Yi Lin, Kun Wang, Jing Yu, Hao Tang, Dai-Wen Pang, Zhi-Ling Zhang. On-chip dual detection of cancer biomarkers directly in serum based on self-assembled magnetic bead patterns and quantum dots. Biosensors and Bioelectronics 2013; 41: 129 doi: 10.1016/j.bios.2012.08.007
|
| 207 |
Fu-Tao Zhao, Zhan-Sheng Jia, Qun Yang, Le Song, Xiao-Jing Jiang. S100A14 Promotes the Growth and Metastasis of Hepatocellular Carcinoma. Asian Pacific Journal of Cancer Prevention 2013; 14(6): 3831 doi: 10.7314/APJCP.2013.14.6.3831
|
| 208 |
Nabil M. Abdel-Hamid, Amer Hasan Abdullah. Serum histamine and acetylcholine variations as new noninvasive biochemical markers in staging of experimental hepatocellular carcinoma. Clinical and Experimental Medicine 2019; 19(1): 115 doi: 10.1007/s10238-018-0537-y
|
| 209 |
Michela Di Michele, Simone Marcone, Lucia Cicchillitti, Anna Della Corte, Cristiano Ferlini, Giovanni Scambia, Maria Benedetta Donati, Domenico Rotilio. Glycoproteomics of paclitaxel resistance in human epithelial ovarian cancer cell lines: Towards the identification of putative biomarkers. Journal of Proteomics 2010; 73(5): 879 doi: 10.1016/j.jprot.2009.11.012
|
| 210 |
Stefan Heringlake, Michael Hofdmann, Anette Fiebeler, Michael P. Manns, Wolff Schmiegel, Andrea Tannapfel. Identification and expression analysis of the aldo–ketoreductase1-B10 gene in primary malignant liver tumours. Journal of Hepatology 2010; 52(2): 220 doi: 10.1016/j.jhep.2009.11.005
|
| 211 |
Atsushi Nanashima, Syuuichi Tobinaga, Masaki Kunizaki, Satoshi Miuma, Naota Taura, Hiroaki Takeshita, Shigekazu Hidaka, Terumitsu Sawai, Kazuhiko Nakao, Takeshi Nagayasu. Strategy of treatment for hepatocellular Carcinomas with vascular infiltration in patients undergoing hepatectomy. Journal of Surgical Oncology 2010; 101(7): 557 doi: 10.1002/jso.21534
|
| 212 |
Hana Park, Jun Yong Park. Clinical Significance of AFP and PIVKA-II Responses for Monitoring Treatment Outcomes and Predicting Prognosis in Patients with Hepatocellular Carcinoma. BioMed Research International 2013; 2013: 1 doi: 10.1155/2013/310427
|
| 213 |
Neven A. Hagag, Yasser B. M. Ali, Ahmed A. Elsharawy, Roba M. Talaat. Clinical Impact of Circulated miR-1291 in Plasma of Patients with Liver Cirrhosis (LC) and Hepatocellular Carcinoma (HCC): Implication on Glypican-3 Expression. Journal of Gastrointestinal Cancer 2020; 51(1): 234 doi: 10.1007/s12029-019-00234-9
|
| 214 |
Priyal Chikhaliwala, Sudeshna Chandra. Poly‐amidoamine Dendrimers@Fe3O4 Based Electrochemiluminescent Nanomaterials for Biosensing of Liver Cancer Biomarkers. Electroanalysis 2020; 32(11): 2404 doi: 10.1002/elan.202060075
|
| 215 |
Yousri M. Hussein, Fouad E. Morad, Magda A. Gameel, Wafaa A. Emam, Wael H. El Sawy, Shereen A. El Tarhouny, Eman S. Bayomy, Nermin Raafat. MAGE-4 gene m-RNA and TGF in blood as potential biochemical markers for HCC in HCV-infected patients. Medical Oncology 2012; 29(5): 3055 doi: 10.1007/s12032-012-0257-1
|
| 216 |
Xiaoting Li, Beibei Chen, Man He, Guangyang Xiao, Bin Hu. Gold nanoparticle labeling with tyramide signal amplification for highly sensitive detection of alpha fetoprotein in human serum by ICP-MS. Talanta 2018; 176: 40 doi: 10.1016/j.talanta.2017.08.007
|
| 217 |
Anastasia Asimakopoulou, Mihael Vucur, Tom Luedde, Silvia Schneiders, Stavroula Kalampoka, Thomas Weiss, Ralf Weiskirchen. Perilipin 5 and Lipocalin 2 Expression in Hepatocellular Carcinoma. Cancers 2019; 11(3): 385 doi: 10.3390/cancers11030385
|
| 218 |
Ahmed A. Raouf, Eman A. Gaweesh, Hanaa M. Badran, Manal O. El-Hamshary, Mohamed Shereef A. Hamed. Molecular diagnosis of hepatocellular carcinoma. Egyptian Liver Journal 2014; 4(1): 20 doi: 10.1097/01.ELX.0000440959.92481.b1
|
| 219 |
Gurjot Singh, Eric M Yoshida, Sahaj Rathi, Vladimir Marquez, Peter Kim, Siegfried R Erb, Baljinder S Salh. Biomarkers for hepatocellular cancer. World Journal of Hepatology 2020; 12(9): 558-573 doi: 10.4254/wjh.v12.i9.558
|
| 220 |
XIAOBO JIA, YINGTANG GAO, DAOKUAN ZHAI, JIAO LIU, YAJIE WANG, LI JING, ZHI DU. Survivin is not a promising serological maker for the diagnosis of hepatocellular carcinoma. Oncology Letters 2015; 9(5): 2347 doi: 10.3892/ol.2015.3050
|
| 221 |
Zeting Huang, Bin Zhou, Zheng Li, Cantong Liu, Chunwen Zheng, Ruijie Zeng, Chaoqun Hong, Liyan Xu, Enmin Li, Yuhui Peng, Yiwei Xu. Serum interleukin-8 as a potential diagnostic biomarker in esophageal squamous cell carcinoma. Cancer Biomarkers 2020; 29(1): 139 doi: 10.3233/CBM-201687
|
| 222 |
Joon Seon Yang, Juan Qiao, Jin Yong Kim, Liping Zhao, Li Qi, Myeong Hee Moon. Online Proteolysis and Glycopeptide Enrichment with Thermoresponsive Porous Polymer Membrane Reactors for Nanoflow Liquid Chromatography-Tandem Mass Spectrometry. Analytical Chemistry 2018; 90(5): 3124 doi: 10.1021/acs.analchem.7b04273
|
| 223 |
Christophe Duvoux. Transplantation hépatique pour carcinome hépatocellulaire. Gastroentérologie Clinique et Biologique 2006; 30(12): 1343 doi: 10.1016/S0399-8320(06)73551-5
|
| 224 |
Zhiyong Guo, Lin Wu, Yufang Hu, Sui Wang, Xing Li. Potential-resolved “in-electrode” type electrochemiluminescence immunoassay based on functionalized g-C 3 N 4 nanosheet and Ru-NH 2 for simultaneous determination of dual targets. Biosensors and Bioelectronics 2017; 95: 27 doi: 10.1016/j.bios.2017.03.013
|
| 225 |
Jingjing Li, Sang Hyuk Lee, Dong Kyu Yoo, Ho Chul Woo, Sung Hwa Jhung, Milica Jović, Hubert Girault, Hye Jin Lee. A spatially multiplexed voltammetric magneto-sandwich assay involving Fe3O4/Fe-based metal-organic framework for dual liver cancer biomarkers. Sensors and Actuators B: Chemical 2023; 380: 133313 doi: 10.1016/j.snb.2023.133313
|
| 226 |
Kanjana Thumanu, Suleeporn Sangrajrang, Thiravud Khuhaprema, Anant Kalalak, Waraporn Tanthanuch, Siwatt Pongpiachan, Philip Heraud. Diagnosis of liver cancer from blood sera using FTIR microspectroscopy: a preliminary study. Journal of Biophotonics 2014; 7(3-4): 222 doi: 10.1002/jbio.201300183
|
| 227 |
Cedric Badowski, Bing He, Lana X. Garmire. Blood-derived lncRNAs as biomarkers for cancer diagnosis: the Good, the Bad and the Beauty. npj Precision Oncology 2022; 6(1) doi: 10.1038/s41698-022-00283-7
|